Cangrelor 68083-0412-10

Package NDC

68083-0412-10

Manufacturer: Gland Pharma Limited
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: August 11, 2025
Listing Expires: December 31, 2026
Application: ANDA213551

Need to source Cangrelor? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Cangrelor	50 mg/1

Drug Class

P2Y12 Platelet Inhibitor [EPC]Decreased Platelet Aggregation [PE]P2Y12 Platelet Inhibitor [EPC]

Selected Package

68083-0412-10Selected

10 VIAL, SINGLE-DOSE in 1 CARTON (68083-412-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE